
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $100K | -- | -- | -$0.14 | -- |
07/30/2025 | Q2 | -- | -- | -- | -$0.14 | -- |
05/06/2025 | Q1 | -- | $4K | -$0.17 | -$0.14 | -$0.03 |
02/11/2025 | Q4 | -- | $23K | -$0.16 | -$0.14 | -$0.02 |
10/29/2024 | Q3 | $100K | $22K | -$0.17 | -$0.15 | -$0.02 |
07/30/2024 | Q2 | $100K | $72K | -$0.16 | -$0.15 | -$0.01 |
04/25/2024 | Q1 | -- | $18K | -$0.19 | -$0.15 | -$0.04 |
02/13/2024 | Q4 | $500K | $550K | -$0.18 | -$0.11 | -$0.07 |
11/01/2023 | Q3 | -- | -- | -$0.20 | -$0.16 | -$0.04 |
08/02/2023 | Q2 | -- | -- | -$0.21 | -$0.16 | -$0.05 |
04/26/2023 | Q1 | -- | -- | -$0.21 | -$0.17 | -$0.04 |
02/15/2023 | Q4 | -- | -- | -$0.18 | -$0.17 | -$0.01 |
11/09/2022 | Q3 | -- | -- | -$0.20 | -- | -- |
08/02/2022 | Q2 | -- | -- | -$0.20 | -$0.17 | -$0.03 |
04/27/2022 | Q1 | -- | -- | -$0.18 | -$0.16 | -$0.02 |
02/15/2022 | Q4 | -- | -- | -$0.18 | -$0.16 | -$0.02 |
10/28/2021 | Q3 | -- | -- | -$0.19 | -$0.12 | -$0.07 |
08/03/2021 | Q2 | -- | -- | -$0.17 | -$0.14 | -$0.03 |
04/28/2021 | Q1 | -- | -- | -$0.16 | -$0.13 | -$0.03 |
02/10/2021 | Q4 | -- | -- | -$0.19 | -$0.16 | -$0.03 |
10/29/2020 | Q3 | -- | -- | -$0.19 | -$0.18 | -$0.01 |
08/05/2020 | Q2 | -- | -- | -$0.21 | -$0.18 | -$0.03 |
04/30/2020 | Q1 | -- | -- | -$0.22 | -$0.16 | -$0.06 |
02/12/2020 | Q4 | -- | -- | -$0.18 | -$0.17 | -$0.02 |
10/30/2019 | Q3 | -- | -- | -$0.19 | -$0.19 | -- |
08/07/2019 | Q2 | -- | -- | -$0.24 | -$0.20 | -$0.05 |
05/01/2019 | Q1 | -- | -- | -$0.24 | -$0.20 | -$0.05 |
02/12/2019 | Q4 | -- | -- | -$0.22 | -- | -- |
11/01/2018 | Q3 | -- | -- | -$0.28 | -- | -- |
08/08/2018 | Q2 | -- | -- | -$0.26 | -- | -- |
05/03/2018 | Q1 | -- | -- | -$0.26 | -- | -- |
02/13/2018 | Q4 | -- | -- | -$0.21 | -- | -- |
11/06/2017 | Q3 | -- | -- | -$0.28 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.31 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.31 | -- | -- |
03/07/2017 | Q4 | -- | -- | -$0.28 | -- | -- |
11/08/2016 | Q3 | -- | -- | -$0.56 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.23 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.22 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.36 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.12 | -- | -- |
Atomera reported $4K worth of top line sales in its most recent quarter.
Atomera announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.14 per share.
Atomera reported $4K that represents $0.00 per share over the last quarter.
Atomera's earnings are forecast to decrease from -$0.68 per share to -$0.58 per share next year representing a decrease of -16.18%.
Atomera's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.